Advances in Phototherapy and Sonodynamic Therapy, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 779
Special Issue Editors
Interests: nanoformulations; molecular imaging; nanoprobes; theranostic strategy; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: nano/microstuctural drug carriers; polymeric drugs; controlled release; theranostics; antiviral angents; antibacterial systems; novel drugs for photodynamic therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanomaterial-mediated photo and sonodynamic therapeutic cancer treatments provide significant hope for enhancing patients’ quality of life. Phototherapy is a prominent non-invasive treatment modality in which nanomaterials absorb incident light and generate thermal heat (to mediate photothermal therapy—PTT) and cytotoxic reactive oxygen species (to mediate photodynamic therapy—PDT), allowing them to tackle tumors efficiently in both in vitro and in vivo models. Meanwhile, sonodynamic therapy (SDT) leverages sonosensitizers exposed to low-intensity ultrasound for tumor ablation.
Both of these therapeutic modalities have unique advantages, such as minimal invasiveness, spatiotemporal controllability, deep tissue penetration, a short recovery period, etc. Moreover, the flexibility of biomaterials allows phototherapy/SDT to be combined with other imaging tools (MRI, CT, fluorescence)/cancer treatments (chemo, radio, immuno, etc.) for synergistic therapeutic/theranostic effects, further improving therapeutic outcomes.
This Special Issue of Pharmaceutics will focus on the advances in nanomaterial-mediated photo/sonodymic approaches (including, but not limited to, phototherapy, photodynamic therapy, sonodynamic therapy, theranostic platforms) used to combat cancer. High-quality quality research papers, reviews, and are welcome.
We look forward to receiving your submissions.
Prof. Dr. Chia-Hao Su
Prof. Dr. Maria Nowakowska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photothermal therapy
- photodynamic therapy
- sonodynamic therapy
- nanomaterials
- theranostics
- synrgestic therapy
- combination therapy
